Hydrogen sulfide mediates cardioprotection through Nrf2 signaling.
Hydrogen sulfide mediates cardioprotection through Nrf2 signaling.
复制标题
DOI:
10.1161/circresaha.109.199919
复制
发表时间:
2009-08-14
影响因子:
20.1
通讯作者:
Lefer DJ
中科院分区:
文献类型:
--
作者:
Calvert JW;Jha S;Gundewar S;Elrod JW;Ramachandran A;Pattillo CB;Kevil CG;Lefer DJ
The recent emergence of hydrogen sulfide (H2S) as a potent cardioprotective signaling molecule necessitates the elucidation of its cytoprotective mechanisms. The current study evaluated potential mechanisms of H2S-mediated cardioprotection using an in vivo model of pharmacological preconditioning (PC). H2S (100 μg/kg), or vehicle was administered to mice via an intravenous injection 24 hr prior to myocardial ischemia. Treated and untreated mice were then subjected to 45 min of myocardial ischemia followed by reperfusion for up to 24 hr, during which time the extent of myocardial infarction was evaluated, circulating troponin-I levels were measured, and the degree of oxidative stress was evaluated. In separate studies myocardial tissue was collected from treated and untreated mice during the early (30 min and 2hr) and late (24 hr) PC periods to evaluate potential cellular targets of H2S. Initial studies revealed that H2S provided profound protection against ischemic injury as evidenced by significant decreases in infarct size, circulating troponin-I levels, and oxidative stress. During the early PC period H2S increased the nuclear localization of Nrf2, a transcription factor that regulates the gene expression of a number of antioxidants, and increased the phosphorylation of PKCε and STAT-3. During the late PC period, H2S increased the expression of antioxidants (HO-1 and Trx1), increased the expression of HSP90, HSP70, Bcl-2, Bcl-xL, and COX-2 and also inactivated the pro-apoptogen Bad. These results reveal that the cardioprotective effects of H2S are mediated in large part by a combination of antioxidant and anti-apoptotic signaling.